Euflexxa Alternatives Compared
| Euflexxa (sodium hyaluronate) | Meloxicam | Celebrex (celecoxib) |
|
|---|
| Euflexxa (sodium hyaluronate) | Meloxicam | Celebrex (celecoxib) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Osteoarthritis. Euflexxa may also be used for purposes not listed in this medication guide. |
Prescription only
Meloxicam is effective for the short-term relief of pain and inflammation associated with arthritis; however, like other NSAIDs, it has the potential to adversely affect the stomach or heart and... View more |
Prescription only
Celebrex is a COX-2-specific NSAID that has a lower propensity for gastrointestinal side effects than many other NSAIDs; however, it still may increase the risk of serious cardiovascular thrombotic... View more |
Related suggestions Osteoarthritis
|
|||||||||||||||
| More about Euflexxa (sodium hyaluronate) | More about Meloxicam | More about Celebrex (celecoxib) | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Euflexxa has an average rating of 6.1 out of 10 from a total of 261 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 35% reported a negative effect. |
Meloxicam has an average rating of 6.3 out of 10 from a total of 600 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 33% reported a negative effect. |
Celebrex has an average rating of 7.0 out of 10 from a total of 226 ratings on Drugs.com. 64% of reviewers reported a positive effect, while 23% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
View all Euflexxa side effects |
View all Meloxicam side effects |
View all Celebrex side effects |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
Lower cost generic |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Meloxicam prices |
View all Celebrex prices |
||||||||||||||||
| Dosage Forms | ||||||||||||||||||
|
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Other sodium hyaluronate brands include: Durolane, Gelsyn-3, Hyalgan, Supartz, Supartz FX | Mobic | Other celecoxib brands include: Elyxyb | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
|
N/A |
20 hours |
11 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category N
Not classified
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
Prior To 30 Weeks Gestation
Category D
Positive evidence of risk
Starting At 30 Weeks Gestation See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
Prior To 30 Weeks Gestation
Category D
Positive evidence of risk
Starting At 30 Weeks Gestation See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 2 drugs are known to interact with Euflexxa:
|
A total of 464 drugs are known to interact with Meloxicam:
|
A total of 447 drugs are known to interact with Celebrex:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
N/A |
April 13, 2000 |
December 31, 1998 |
||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient Resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.